(Board of Supervisors regular meeting is Tuesday)....The meeting will begin with presentations.

The leading Mycosis Fungoides Companies such as Innate Pharma, Soligenix, Bristol-Myers Squibb and others. Promising Mycosis ...

The "Blood Market 2025-2029" has been added to ResearchAndMarkets.com's offering. The global blood market is poised to expand by USD 2.59 billion from 2024 to 2029, with an anticipated CAGR of 5.7%.

Dr. Benjamin Weinberg, Associate Professor at Georgetown University and Principal Investigator of CytoDyn’s colorectal cancer ("CRC”) program, will present the Company’s clinical data at the ESMO ...

FDA decision will enable Iksuda to expand its ongoing clinical trial in the US, Australia and Singapore. Preliminary data from an ongoing dose-escalation study of IKS014 has shown ...

Biljana Naumovic, US President, oncology, solid tumor, Johnson & Johnson Innovative Medicine discusses key takeaways from the ...

Tectonic Therapeutic (TECX) has been added to the broad-market Russell 3000 Index as part 2025 Russell US Indexes annual reconstitution.

Palvella Therapeutics, Inc. (Palvella), a clinical-stage biopharmaceutical company focused on developing and commercializing ...

If you haven’t heard of this fast-rising ASX 200 stock yet, that’s about to change. The post Up 36% in a year, why this $8 billion ASX 200 stock has still a 'strong growth forecast' appeared first on ...